184
Participants
Start Date
December 31, 2003
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2011
Fludarabine
Cyclophosphamide
Rituximab
Pentostatin
New York Oncology Hematology, PC, Albany
Medical Oncology Associates, Kingston
Alliance Hematology Oncology PA, Westminster
Northwestern Carolina Oncology Hemato, Hickory
Cancer Centers of Florida, P.A., Ocoee
Hope Center, Terre Haute
St Joseph Oncology, Inc, Saint Joseph
Texas Oncology Cancer Center-Sugar Land, Sugar Land
South Texas Cancer Center-McAllen, McAllen
Yakima Valley Mem Hosp/North Star Lodge, Yakima
Cancer Care Northwest-South, Spokane
Collaborators (1)
Astex Pharmaceuticals, Inc.
INDUSTRY
US Oncology Research
INDUSTRY